Semaphorin 7A protein variants differentially regulate T-cell activity

Transfusion

Volumn 53, Issue 2, 2013, Pages 270-283

  Gras, Christiane ^a   Eiz Vesper, Britta ^a   Seltsam, Axel ^a   Immenschuh, Stephan ^a   Blasczyk, Rainer ^a   Figueiredo, Constança ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; GRANZYME B; PROTEIN VARIANT; SEMAPHORIN; SEMAPHORIN 7A; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL PROLIFERATION; GENE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NORMAL HUMAN; PHENOTYPE; SEMAPHORIN 7A GENE; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD3; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; FOCAL ADHESION KINASE 1; GENETIC VARIATION; GPI-LINKED PROTEINS; HEK293 CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; SEMAPHORINS; SOLUBILITY; T-LYMPHOCYTES;

EID: 84873428485     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03812.x     Document Type: Article

References (32)

1. Kolodkin AL, Matthes DJ, Goodman CS,. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993; 75: 1389-99.
2. Gherardi E, Love CA, Esnouf RM, Jones EY,. The sema domain. Curr Opin Struct Biol 2004; 14: 669-78.
3. Pasterkamp RJ, Kolodkin AL,. Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol 2003; 13: 79-89.
4. Yu HH, Kolodkin AL,. Semaphorin signaling: a little less per-plexin. Neuron 1999; 22: 11-4.
5. Comeau MR, Johnson R, DuBose RF, Petersen M, Gearing P, VandenBos T, Park L, Farrah T, Buller RM, Cohen JI, Strockbine LD, Rauch C, Spriggs MK,. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 1998; 8: 473-82.
6. Lange C, Liehr T, Goen M, Gebhart E, Fleckenstein B, Ensser A,. New eukaryotic semaphorins with close homology to semaphorins of DNA viruses. Genomics 1998; 51: 340-50.
7. Xu X, Ng S, Wu ZL, Nguyen D, Homburger S, Seidel-Dugan C, Ebens A, Luo Y,. Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins. J Biol Chem 1998; 273: 22428-34.
8. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, Tessier-Lavigne M, Comoglio PM,. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99: 71-80.
9. Suzuki K, Okuno T, Yamamoto M, Pasterkamp RJ, Takegahara N, Takamatsu H, Kitao T, Takagi J, Rennert PD, Kolodkin AL, Kumanogoh A, Kikutani H,. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 2007; 446: 680-4.
10. Pasterkamp RJ, Peschon JJ, Spriggs MK, Kolodkin AL,. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 2003; 424: 398-405.
11. Holmes S, Downs AM, Fosberry A, Hayes PD, Michalovich D, Murdoch P, Moores K, Fox J, Deen K, Pettman G, Wattam T, Lewis C,. Sema7A is a potent monocyte stimulator. Scand J Immunol 2002; 56: 270-5.
12. Czopik AK, Bynoe MS, Palm N, Raine CS, Medzhitov R,. Semaphorin 7A is a negative regulator of T cell responses. Immunity 2006; 24: 591-600.
13. Koh JM, Oh B, Lee JY, Kimm K, Kim GS, Park BL, Cheong HS, Shin HD, Hong JM, Kim TH, Park EK, Kim SY,. Association study of semaphorin 7a (sema7a) polymorphisms with bone mineral density and fracture risk in postmenopausal Korean women. J Hum Genet 2006; 51: 112-7.
14. Seltsam A, Strigens S, Levene C, Yahalom V, Moulds M, Moulds JJ, Hustinx H, Weisbach V, Figueroa D, Bade-Doeding C, DeLuca DS, Blasczyk R,. The molecular diversity of Sema7A, the semaphorin that carries the JMH blood group antigens. Transfusion 2007; 47: 133-46.
15. Richard M, St-Laurent J, Perreault J, Long A, St-Louis M,. A new SEMA7A variant found in Native Americans with alloantibody. Vox Sang 2011; 100: 322-6.
16. Scott GA, McClelland LA, Fricke AF,. Semaphorin 7a promotes spreading and dendricity in human melanocytes through beta1-integrins. J Invest Dermatol 2008; 128: 151-61.
17. Lazova R, Gould Rothberg BE, Rimm D, Scott G,. The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis. Am J Dermatopathol 2009; 31: 177-81.
18. Figueiredo C, Wittmann M, Wang D, Dressel R, Seltsam A, Blasczyk R, Eiz-Vesper B,. Heat shock protein 70 (HSP70) induces cytotoxicity of T-helper cells. Blood 2009; 113: 3008-16.
19. Heutinck KM, ten Berge IJ, Hack CE, Hamann J, Rowshani AT,. Serine proteases of the human immune system in health and disease. Mol Immunol 2010; 47: 1943-55.
20. Okoye IS, Wilson MS,. CD4(+) T helper 2 cells-microbial triggers, differentiation requirements and effector functions. Immunology 2011; 134: 368-77.
21. Petersen CM, Christiansen BS, Kaltoft K,. Binding, uptake and degradation of human recombinant interleukin-2 (125 ala) in activated human T- and B-lymphocytes and in monocyte-macrophages. Tissue Antigens 1987; 29: 257-72.
22. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, Casciola-Rosen L,. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity 1998; 8: 451-60.
23. Schroder K, Hertzog PJ, Ravasi T, Hume DA,. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163-89.
24. Martorelli D, Muraro E, Merlo A, Turrini R, Rosato A, Dolcetti R,. Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer. Int Rev Immunol 2010; 29: 371-402.
25. Jaimes Y, Figueiredo C, Blasczyk R,. Silencing the expression of platelet endothelial cell adhesion molecule-1 prevents allogeneic T-cell cytotoxicity. Transfusion 2010; 50: 1988-2000.
26. Cabrini G, Falzoni S, Forchap SL, Pellegatti P, Balboni A, Agostini P, Cuneo A, Castoldi G, Baricordi OR, Di Virgilio F,. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 2005; 175: 82-9.
27. Mudad R, Rao N, Issitt PD, Roy RB, Combs MR, Telen MJ,. JMH variants: serologic, clinical, and biochemical analyses in two cases. Transfusion 1995; 35: 925-30.
28. Long HM, Leese AM, Chagoury OL, Connerty SR, Quarcoopome J, Quinn LL, Shannon-Lowe C, Rickinson AB,. Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition. J Immunol 2011; 187: 92-101.
29. Merlo A, Turrini R, Bobisse S, Zamarchi R, Alaggio R, Dolcetti R, Mautner J, Zanovello P, Amadori A, Rosato A,. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors. J Immunol 2010; 184: 5895-902.
30. Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, Brenchley JM, Hill BJ, Roederer M, Douek DC, Koup RA,. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 2006; 203: 2865-77.
31. Jellison ER, Kim SK, Welsh RM,. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol 2005; 174: 614-8.
32. Landmeier S, Altvater B, Pscherer S, Eing BR, Kuehn J, Rooney CM, Juergens H, Rossig C,. Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function. Cancer Res 2007; 67: 8335-43.